Mark McClellan, MD, PhD

Articles

Value-Based Arrangements May Be More Prevalent Than Assumed

February 13, 2019

We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.